Author Archives: Joana Fernandes, PhD

Sarcoidosis Patients Have Increased Risk of Hospital Infection, Finds Study That Spanned 35+ Years

Sarcoidosis patients are two times more susceptible to hospitalized infection than the general population, especially those treated with glucocorticoid therapy, according to results of a new study. The study, titled “Sarcoidosis Increases Risk Of Hospitalized Infection: A Population-Based Study 1976-2013,” was published in the journal Annals of the…

Rare Case of Neurosarcoidosis in Patient with Lung Sarcoidosis Treated with Corticosteroids

Symptoms of  neurological impairment linked to lung sarcoidosis, an unusual condition known as neurosarcoidosis,  were treated in a woman using an immunosuppressive therapy based on corticosteroids, researchers reported in a case study. The study, “Dementia, Gait Disturbance, And Urinary Incontinence In A Patient With Pulmonary Sarcoidosis,” published in the journal Respirology…

Corticosteroid Therapy Started Early Seen to Notably Benefit Cardiac Sarcoidosis Patients

The sooner patients with cardiac sarcoidosis start corticosteroid therapy, the better are their chances of improvement and positive outcomes,a new study published in the International Journal of Cardiology reports. The study, “Impact Of Early Initiation Of Corticosteroid Therapy On Cardiac Function And Rhythm In Patients With Cardiac Sarcoidosis,” was conducted…

Researchers Report Case of Sarcoidosis, Pulmonary Hypertension Patient

Sarcoidosis patients may develop pulmonary hypertension that leads to severe heart complications, according to a study published in the journal Case Reports in Cardiology. In the study, “Multifactorial Etiology Pulmonary Hypertension In A Patient With Sarcoidosis,” researchers described a case of pulmonary sarcoidosis, heart failure, and pulmonary hypertension (PH) that…